Certara Overview

  • Status
  • Public

  • Employees
  • 1,114

Employees
  • Stock Symbol
  • CERT

Stock Symbol
  • Investments
  • 17

  • Share Price
  • $20.19

  • (As of Thursday Closing)

Certara General Information

Description

Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States.

Contact Information

Website
www.certara.com
Formerly Known As
Tripos
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Decision/Risk Analysis
Stock Exchange
NAS
Primary Office
  • Overlook Center
  • Suite 101
  • Princeton, NJ 08540
  • United States
+1 (415) 000-0000

Certara Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Certara Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.19 $20.36 $16.18 - $45.48 $3.23B 160M 503K -$0.06

Certara Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 3,554,703 4,416,264 5,508,372
Revenue 313,601 286,104 243,530 208,511
EBITDA 66,470 58,577 17,868 60,413
Net Income (9,840) (13,266) (49,397) (8,926)
Total Assets 1,501,749 1,511,730 1,269,400 1,037,069
Total Debt 306,956 308,380 299,373 401,379
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Certara Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Certara‘s full profile, request access.

Request a free trial

Certara Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug d
Other Healthcare Technology Systems
Princeton, NJ
1,114 As of 2021
00000
00000000000 00000

000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000000000
Menlo Park, CA
000 As of 0000
00000
000000000 00000

000000

scing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veni
00000 0000000000 0000000000 0000000
Simsbury, CT
00 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Certara Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacific Biosciences Formerly VC-backed Menlo Park, CA 000 00000 000000000 00000
000000 00000000 00 Corporation Simsbury, CT 00 0000000000
00000000 000000000 Private Equity-Backed Montreal, Canada 00 00000000. 00
0000 0000000000000 Venture Capital-Backed Palo Alto, CA 00 000.00 000000000 - 000.00
0000ö000000 Formerly VC-backed New York, NY 000 00000 00000000000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Certara Patents

Certara Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210032682-A1 Methods and apparatus for quantifying protein abundance in tissues via cell free ribonucleic acids in liquid biopsy Pending 28-Mar-2018 0000000000
JP-2022513549-A Methods and apparatus for quantifying protein abundance in tissues mediated by cell-free ribonucleic acid in liquid biopsy Pending 28-Mar-2018 000000000
EP-3775260-A4 Methods and apparatus for quantifying protein abundance in tissues via cell free ribonucleic acids in liquid biopsy Pending 28-Mar-2018 000000000 0
EP-3775260-A1 Methods and apparatus for quantifying protein abundance in tissues via cell free ribonucleic acids in liquid biopsy Pending 28-Mar-2018 0000000000
CA-3094724-A1 Methods and apparatus for quantifying protein abundance in tissues via cell free ribonucleic acids in liquid biopsy Pending 28-Mar-2018 C12Q1/6886
To view Certara’s complete patent history, request access »

Certara Executive Team (27)

Name Title Board Seat Contact Info
William Feehery Chief Executive Officer & Board Member
Justin Edge President
Patrick Smith President
Andrew Schemick Chief Financial Officer
Jieun Choe Chief Marketing Officer, Marketing & Chief Strategy Officer, Strategy
You’re viewing 5 of 27 executive team members. Get the full list »

Certara Board Members (24)

Name Representing Role Since
00000 000000000 00 Self Board Member 000 0000
0000000 0000000 Certara Board Member 000 0000
0000 000000 Certara Board Member 000 0000
0000 000 EQT Board Member 000 0000
00000 0000000 000 Certara Chairman & Board Member 000 0000
You’re viewing 5 of 24 board members. Get the full list »

Certara Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Certara Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Certara‘s full profile, request access.

Request a free trial

Certara Investments & Acquisitions (17)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00 03-Jan-2022 0000000000 00.000 Other Healthcare Technology Systems 0000000 0
00000000 00 01-Oct-2021 0000000000 00000 Business/Productivity Software 0000000 0
0000000 00000 10-Jun-2021 0000000000 Other Healthcare Services 000000 00
000000! 02-Mar-2021 0000000000 00.000 Decision/Risk Analysis 000000000
Pirana 13-Sep-2018 Buyout/LBO Business/Productivity Software 000000 00
You’re viewing 5 of 17 investments and acquisitions. Get the full list »

Certara Subsidiaries (7)

Company Name Industry Location Founded
Pinnacle 21 Business/Productivity Software Blue Bell, PA 2011
0000000000 0000000 Other Healthcare Technology Systems Ann Arbor, MI 0000
00000000 Business/Productivity Software Berlin, Germany 0000
0000000 0000000 00 Other Healthcare Services Kidlington, United Kingdom 0000
000000! Decision/Risk Analysis Hilversum, Netherlands 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »

Certara Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 30-Apr-2002 00000 00000 00 00.00 Completed
  • 2 buyers
0000000 01-May-2000 0000 00000 Completed
  • 3 buyers
Arena Pharmaceuticals 22-Feb-1999 Later Stage VC 0000 Completed
  • 5 buyers
To view Certara’s complete exits history, request access »